IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.360
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
1.370
+0.010 (0.74%)
After-hours: Jun 26, 2026, 6:09 PM EDT
IN8bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for IN8bio stock have an average target of 5.00, with a low estimate of 4.00 and a high estimate of 6.00. The average target predicts an increase of 267.65% from the current stock price of 1.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IN8bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 | Buy | Reiterates | $6 | +341.18% | Jun 4, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $4 | Buy | Reiterates | $4 | +194.12% | Jun 1, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $5 | Buy | Maintains | $5 | +267.65% | May 22, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
829.75K
EPS This Year
-1.24
from -4.44
EPS Next Year
-1.06
from -1.24
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 3.3M | |
| Avg | n/a | 829,750 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 3,834.3% |
| Avg | - | 1,211.4% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -1.24 | -1.06 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.